Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	530.21M
Revenue (ttm)	307.34M
Net Income (ttm)	845.00K
Shares Out	12.94M
EPS (ttm)	0.09
PE Ratio	627.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,484
Average Volume	15,542
Open	42.00
Previous Close	40.00
Day's Range	40.00 - 42.00
52-Week Range	19.88 - 52.79
Beta	0.32
RSI	48.74
Earnings Date	Aug 8, 2025

About Verve Therapeutics

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. The company is involved in the retail pharmacy business; and distribution of pharmaceutical products. It also trades in shares and securities; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In 2024, Novelix Pharmaceuticals's revenue was 307.34 million, an increase of 583.80% compared to the previous year's 44.95 million. Earnings were 845,000, an increase of 711.56%.